Recent Finacing
Recent Raise
Oxford BioTherapeutics is a clinical-stage oncology company developing antibody-based immuno-oncology therapies and ADCs using OGAP proteomics target-discovery platform and tumour culture library, with Phase I programs and pharma partnerships.
